Skip to main content
. 2015 Oct 16;106(11):1493–1498. doi: 10.1111/cas.12805

Figure 3.

Figure 3

Lck‐specific cytotoxicity of peptide‐stimulated peripheral blood mononuclear cells (PBMC). PBMC from the three HLA‐A2+ cancer patients were stimulated vitro with each of the Lck33–47, Lck374–388 and Lck487–501 peptides followed by testing of their cytotoxicity against HLA‐A2+ Lck+ SW620, HLA‐A2+ Lck LNCaP, and HLA‐A2 Lck+ SQ‐1 cells by a 6‐h 51Cr release assay at the 15:1, 10:1 and 5:1 of effector to target cell ratios, respectively. Representative results at the 10:1 ratio are shown in the figure. *P < 0.05 (statistically significant).